Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Children After Vaccination”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Large-scale testing (Phase 3)Study completedNCT01026038
What this trial is testing

Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddler Dose.

Who this might be right for
13-valent Pneumococcal VaccineImmunizationSafety+1 more
Pfizer 263
Large-scale testing (Phase 3)Study completedNCT01983540
What this trial is testing

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Who this might be right for
DiphtheriaTetanusWhooping Cough+3 more
Sanofi Pasteur, a Sanofi Company 558
Large-scale testing (Phase 3)Study completedNCT01900444
What this trial is testing

Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea

Who this might be right for
Japanese Encephalitis
Sanofi Pasteur, a Sanofi Company 119
Not applicableStudy completedNCT00161941
What this trial is testing

Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216

Who this might be right for
Meningococcal Meninigitis, Serogroup C
Pfizer 321
Not applicableStudy completedNCT00514033
What this trial is testing

A Post-marketing Safety Study of GSK Bio IPV Vaccine (PoliorixTM) in Korean Children

Who this might be right for
Poliomyelitis
GlaxoSmithKline 349
Not applicableStudy completedNCT01207583
What this trial is testing

Prevenar (PCV-7) Post-Licensure Safety Study In Russia

Who this might be right for
Healthy Children After Vaccination
Pfizer 100
Post-approval studies (Phase 4)Study completedNCT02521974
What this trial is testing

Evaluate the Safety and Immunogenicity of Oral Polio Vaccine Type 2 in Infants and Children

Who this might be right for
Adverse Event Following Immunisation
Fidec Corporation 164
Large-scale testing (Phase 3)Study completedNCT01027845
What this trial is testing

Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese Children

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 360
Large-scale testing (Phase 3)Study completedNCT04490499
What this trial is testing

A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013)

Who this might be right for
Hepatitis B
Merck Sharp & Dohme LLC 207
Large-scale testing (Phase 3)Study completedNCT01266993
What this trial is testing

Persistence and Booster Study of GSK Biologicals' Meningococcal Vaccine (GSK134612) in Healthy Children

Who this might be right for
Infections, MeningococcalMeningococcal Vaccines
GlaxoSmithKline 271
Not applicableStudy completedNCT01105559
What this trial is testing

Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine

Who this might be right for
DiphtheriaTetanusWhooping Cough+2 more
Sanofi 455
Testing effectiveness (Phase 2)Study completedNCT00307567
What this trial is testing

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

Who this might be right for
Acellular PertussisTetanusHepatitis B+3 more
GlaxoSmithKline 689
Testing effectiveness (Phase 2)Looking for participantsNCT05422508
What this trial is testing

Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination

Who this might be right for
Varicella
Green Cross Corporation 230
Not applicableStudy completedNCT00768833
What this trial is testing

Study Evaluating the Nasopharyngeal Carriage in Healthy Children

Who this might be right for
Healthy Subjects
Pfizer 242
Large-scale testing (Phase 3)Study completedNCT00693186
What this trial is testing

Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA

Who this might be right for
Hepatitis B
Sanofi Pasteur, a Sanofi Company 410
Large-scale testing (Phase 3)Study completedNCT01107275
What this trial is testing

Early Rabies Vaccine Immunization in Primary School Children

Who this might be right for
Rabies Prevention
Provincial Public Health Office, Phetchabun 703
Not applicableWithdrawnNCT01803425
What this trial is testing

Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri Lanka

Who this might be right for
Immunisation Against Streptococcus Pneumoniae
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT00333450
What this trial is testing

Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines.

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 120
Post-approval studies (Phase 4)Study completedNCT00310713
What this trial is testing

Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine

Who this might be right for
Prevention of Meningococcal Infection
Novartis Vaccines 33
Testing effectiveness (Phase 2)Study completedNCT00679159
What this trial is testing

MVA85A in Healthy Children and Infants

Who this might be right for
Tuberculosis
University of Oxford 168
Next Page